No Data
Monday Market Falls, Chinese Stocks Climb, Indecies Rebalance | Live Stock
Express News | Warm Autoimmune Hemolytic Anemia (Waiha) Research Presented by Johnson & Johnson Highlights Profound Disease Burden and Unmet Need for Targeted Treatment Options
Institutional Investors May Adopt Severe Steps After Johnson & Johnson's (NYSE:JNJ) Latest 3.5% Drop Adds to a Year Losses
Johnson & Johnson Says 2 Studies of Potential Early Multiple Myeloma Drug Showed 'Promising' Efficacy
Johnson & Johnson Says Darzalex Faspro Shows Improved Outcomes in Multiple Myeloma Study
Express News | Reported Sunday, Johnson & Johnson Highlights TECVAYLI's Role In Advancing Frontline Multiple Myeloma Care With 100% MRD-Negative Results At ASH 2024